Mallinckrodt (MNK) Tops Q4 EPS by 3c; Therakos Production Issues Noted

Go back to Mallinckrodt (MNK) Tops Q4 EPS by 3c; Therakos Production Issues Noted

Mallinckrodt (MNK) Sees Notable Pressure

November 29, 2016 9:52 AM EST

Mallinckrodt (NYSE: MNK) is seeing notable weakness following earning this morning. The call is ongoing. Shares are down 6.6%

... More

BMO Capital Reiterates Outperform on Mallinckrodt (MNK) Following Solid 4Q

November 29, 2016 9:43 AM EST

BMO Capital reiterated an Outperform rating and $92.00 price target on Mallinckrodt plc (NYSE: MNK) following the company's 4Q earnings report. Revenue of $887mn came in ahead of the consensus of 874mn, driven largely by Acthar. EPS were $2.04 vs. the consensus of 1.97.... More

Mizuho Securities Remains Bullish on Mallinckrodt (MNK) Following Strong 4Q

November 29, 2016 8:46 AM EST

Mizuho Securities reiterated a Buy rating and $87.00 price target on Mallinckrodt plc (NYSE: MNK) following the company's 4Q earnings report. MNK reported revenues of $887.2M and adjusted EPS of $2.04, both ahead of consensus estimates of $832.1M and $1.90. Total branded sales of $633.1M outperformed consensus estimates of $596.6M.

Analyst Irina Koffler commented,... More

Mallinckrodt Plc (MNK) December weekly 57 straddle priced for movement of 9.6%

November 28, 2016 3:10 PM EST

Mallinckrodt (NYSE: MNK) December weekly 57 straddle priced for movement of 9.6%

... More